Production (Stage)
Replimune Group, Inc.
REPL
$8.98
-$0.39-4.16%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 74.11M | 64.94M | 60.65M | 59.91M | 60.72M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 259.86M | 239.17M | 229.65M | 234.53M | 232.86M |
| Operating Income | -259.86M | -239.17M | -229.65M | -234.53M | -232.86M |
| Income Before Tax | -246.83M | -227.73M | -212.61M | -219.80M | -215.39M |
| Income Tax Expenses | 468.00K | 510.00K | 408.00K | 207.00K | 408.00K |
| Earnings from Continuing Operations | -247.30 | -228.24 | -213.02 | -220.01 | -215.79 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -247.30M | -228.24M | -213.02M | -220.01M | -215.79M |
| EBIT | -259.86M | -239.17M | -229.65M | -234.53M | -232.86M |
| EBITDA | -256.36M | -236.21M | -226.71M | -231.76M | -230.20M |
| EPS Basic | -3.17 | -3.18 | -3.16 | -3.28 | -3.24 |
| Normalized Basic EPS | -1.98 | -1.99 | -1.97 | -2.05 | -2.02 |
| EPS Diluted | -3.17 | -3.18 | -3.16 | -3.28 | -3.24 |
| Normalized Diluted EPS | -1.98 | -1.99 | -1.97 | -2.05 | -2.02 |
| Average Basic Shares Outstanding | 311.12M | 286.89M | 270.03M | 268.22M | 266.28M |
| Average Diluted Shares Outstanding | 311.12M | 286.89M | 270.03M | 268.22M | 266.28M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |